tiprankstipranks
Advertisement
Advertisement

GB:AGY Stock Latest News

Allergy Therapeutics Accelerates Growth on Grassmuno Launch and New Funding
Company AnnouncementsAllergy Therapeutics Accelerates Growth on Grassmuno Launch and New Funding
4d ago
Allergy Therapeutics Names Executive Chairman as It Weighs Dual Hong Kong Listing
PremiumCompany Announcements
Allergy Therapeutics Names Executive Chairman as It Weighs Dual Hong Kong Listing
5d ago
Allergy Therapeutics Links CFO Incentive Award to Share Price and Growth Targets
PremiumCompany Announcements
Allergy Therapeutics Links CFO Incentive Award to Share Price and Growth Targets
2M ago
Allergy Therapeutics Highlights Positive Allergy Trial Data at EAACI 2026
PremiumCompany Announcements
Allergy Therapeutics Highlights Positive Allergy Trial Data at EAACI 2026
2M ago
Allergy Therapeutics boosts funding as Grassmuno launch and peanut vaccine advance
PremiumCompany Announcements
Allergy Therapeutics boosts funding as Grassmuno launch and peanut vaccine advance
4M ago
Allergy Therapeutics Deepens Real-World Data on Grassmuno® With New GRASS Study
PremiumCompany AnnouncementsAllergy Therapeutics Deepens Real-World Data on Grassmuno® With New GRASS Study
5M ago
AGY
Allergy Therapeutics Reshapes Major Shareholding Ahead of Potential Hong Kong Listing
Premium
Company Announcements
Allergy Therapeutics Reshapes Major Shareholding Ahead of Potential Hong Kong Listing
5M ago
Allergy Therapeutics’ VLP Peanut Shows Strong Immune Response in Early-Stage Trial
Premium
Company Announcements
Allergy Therapeutics’ VLP Peanut Shows Strong Immune Response in Early-Stage Trial
5M ago
Allergy Therapeutics showcases new allergy immunotherapy data at AAAAI 2026
PremiumCompany Announcements
Allergy Therapeutics showcases new allergy immunotherapy data at AAAAI 2026
5M ago
Allergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
PremiumCompany Announcements
Allergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
5M ago
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
PremiumCompany Announcements
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
6M ago
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
PremiumCompany Announcements
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
6M ago
Allergy Therapeutics Grants Performance-Linked Share Options to Senior Management
PremiumCompany AnnouncementsAllergy Therapeutics Grants Performance-Linked Share Options to Senior Management
6M ago
Allergy Therapeutics lifts revenues and launches Grassmuno as German TAV transition accelerates
Premium
Company Announcements
Allergy Therapeutics lifts revenues and launches Grassmuno as German TAV transition accelerates
7M ago
Allergy Therapeutics Adds Asia-Focused Expertise to Board Ahead of Potential Hong Kong Listing
Premium
Company Announcements
Allergy Therapeutics Adds Asia-Focused Expertise to Board Ahead of Potential Hong Kong Listing
7M ago
Allergy Therapeutics Wins Shareholder Mandate for Potential Equity Raise Ahead of Hong Kong Dual Listing
PremiumCompany Announcements
Allergy Therapeutics Wins Shareholder Mandate for Potential Equity Raise Ahead of Hong Kong Dual Listing
7M ago
Allergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
PremiumCompany Announcements
Allergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
8M ago
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
PremiumCompany Announcements
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
8M ago
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
PremiumCompany Announcements
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
8M ago
Allergy Therapeutics Reports Stable Financials and Strategic Growth Initiatives
PremiumCompany AnnouncementsAllergy Therapeutics Reports Stable Financials and Strategic Growth Initiatives
8M ago
Allergy Therapeutics Achieves Key Milestone in Peanut Allergy Treatment Trial
Premium
Company Announcements
Allergy Therapeutics Achieves Key Milestone in Peanut Allergy Treatment Trial
8M ago
Allergy Therapeutics Considers Dual Listing on HKEX to Expand Asian Market Presence
Premium
Company Announcements
Allergy Therapeutics Considers Dual Listing on HKEX to Expand Asian Market Presence
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >